Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2014

Open Access 01-12-2014 | Research

The supposed tumor suppressor gene WWOX is mutated in an early lethal microcephaly syndrome with epilepsy, growth retardation and retinal degeneration

Authors: Ghada Abdel-Salam, Michaela Thoenes, Hanan H Afifi, Friederike Körber, Daniel Swan, Hanno Jörn Bolz

Published in: Orphanet Journal of Rare Diseases | Issue 1/2014

Login to get access

Abstract

Background

WWOX, encoding WW domain-containing oxidoreductase, spans FRA16D, the second most common chromosomal fragile site frequently altered in cancers. It is therefore considered a tumor suppressor gene, but its direct implication in cancerogenesis remains controversial.

Methods and results

By whole-exome sequencing, we identified a homozygous WWOX nonsense mutation, p.Arg54*, in a girl from a consanguineous family with a severe syndrome of growth retardation, microcephaly, epileptic seizures, retinopathy and early death, a phenotype highly similar to the abormalities reported in lde/lde rats with a spontaneous functional null mutation of Wwox. As in rats, no tumors were observed in the patient or heterozygous mutation carriers.

Conclusions

Our finding, a homozygous loss-of-function germline mutation in WWOX in a patient with a lethal autosomal recessive syndrome, supports an alternative role of WWOX and indicates its importance for human viability.
Appendix
Available only for authorised users
Literature
1.
go back to reference Dayan S, O’Keefe LV, Choo A, Richards RI: Common chromosomal fragile site FRA16D tumor suppressor WWOX gene expression and metabolic reprograming in cells. Genes Chromosomes Cancer. 2013, 52: 823-831. 10.1002/gcc.22078.CrossRefPubMed Dayan S, O’Keefe LV, Choo A, Richards RI: Common chromosomal fragile site FRA16D tumor suppressor WWOX gene expression and metabolic reprograming in cells. Genes Chromosomes Cancer. 2013, 52: 823-831. 10.1002/gcc.22078.CrossRefPubMed
2.
go back to reference Del Mare S, Salah Z, Aqeilan RI: WWOX: its genomics, partners, and functions. J Cell Biochem. 2009, 108: 737-745. 10.1002/jcb.22298.CrossRefPubMed Del Mare S, Salah Z, Aqeilan RI: WWOX: its genomics, partners, and functions. J Cell Biochem. 2009, 108: 737-745. 10.1002/jcb.22298.CrossRefPubMed
3.
go back to reference Ferguson BW, Gao X, Kil H, Lee J, Benavides F, Abba MC, Aldaz CM: Conditional Wwox deletion in mouse mammary gland by means of two Cre recombinase approaches. PLoS One. 2012, 7: e36618-10.1371/journal.pone.0036618.CrossRefPubMedPubMedCentral Ferguson BW, Gao X, Kil H, Lee J, Benavides F, Abba MC, Aldaz CM: Conditional Wwox deletion in mouse mammary gland by means of two Cre recombinase approaches. PLoS One. 2012, 7: e36618-10.1371/journal.pone.0036618.CrossRefPubMedPubMedCentral
4.
go back to reference Ludes-Meyers JH, Kil H, Parker-Thornburg J, Kusewitt DF, Bedford MT, Aldaz CM: Generation and characterization of mice carrying a conditional allele of the Wwox tumor suppressor gene. PLoS One. 2009, 4: e7775-10.1371/journal.pone.0007775.CrossRefPubMedPubMedCentral Ludes-Meyers JH, Kil H, Parker-Thornburg J, Kusewitt DF, Bedford MT, Aldaz CM: Generation and characterization of mice carrying a conditional allele of the Wwox tumor suppressor gene. PLoS One. 2009, 4: e7775-10.1371/journal.pone.0007775.CrossRefPubMedPubMedCentral
5.
go back to reference Chen ST, Chuang JI, Cheng CL, Hsu LJ, Chang NS: Light-induced retinal damage involves tyrosine 33 phosphorylation, mitochondrial and nuclear translocation of WW domain-containing oxidoreductase in vivo. Neuroscience. 2005, 130: 397-407. 10.1016/j.neuroscience.2004.07.054.CrossRefPubMed Chen ST, Chuang JI, Cheng CL, Hsu LJ, Chang NS: Light-induced retinal damage involves tyrosine 33 phosphorylation, mitochondrial and nuclear translocation of WW domain-containing oxidoreductase in vivo. Neuroscience. 2005, 130: 397-407. 10.1016/j.neuroscience.2004.07.054.CrossRefPubMed
6.
go back to reference Chen ST, Chuang JI, Wang JP, Tsai MS, Li H, Chang NS: Expression of WW domain-containing oxidoreductase WOX1 in the developing murine nervous system. Neuroscience. 2004, 124: 831-839. 10.1016/j.neuroscience.2003.12.036.CrossRefPubMed Chen ST, Chuang JI, Wang JP, Tsai MS, Li H, Chang NS: Expression of WW domain-containing oxidoreductase WOX1 in the developing murine nervous system. Neuroscience. 2004, 124: 831-839. 10.1016/j.neuroscience.2003.12.036.CrossRefPubMed
7.
go back to reference Suzuki H, Katayama K, Takenaka M, Amakasu K, Saito K, Suzuki K: A spontaneous mutation of the Wwox gene and audiogenic seizures in rats with lethal dwarfism and epilepsy. Genes Brain Behav. 2009, 8: 650-660. 10.1111/j.1601-183X.2009.00502.x.CrossRefPubMed Suzuki H, Katayama K, Takenaka M, Amakasu K, Saito K, Suzuki K: A spontaneous mutation of the Wwox gene and audiogenic seizures in rats with lethal dwarfism and epilepsy. Genes Brain Behav. 2009, 8: 650-660. 10.1111/j.1601-183X.2009.00502.x.CrossRefPubMed
8.
go back to reference Li H, Durbin R: Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009, 25: 1754-1760. 10.1093/bioinformatics/btp324.CrossRefPubMedPubMedCentral Li H, Durbin R: Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009, 25: 1754-1760. 10.1093/bioinformatics/btp324.CrossRefPubMedPubMedCentral
9.
go back to reference McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA: The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010, 20: 1297-1303. 10.1101/gr.107524.110.CrossRefPubMedPubMedCentral McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA: The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010, 20: 1297-1303. 10.1101/gr.107524.110.CrossRefPubMedPubMedCentral
10.
go back to reference McLaren W, Pritchard B, Rios D, Chen Y, Flicek P, Cunningham F: Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics. 2010, 26: 2069-2070. 10.1093/bioinformatics/btq330.CrossRefPubMedPubMedCentral McLaren W, Pritchard B, Rios D, Chen Y, Flicek P, Cunningham F: Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics. 2010, 26: 2069-2070. 10.1093/bioinformatics/btq330.CrossRefPubMedPubMedCentral
11.
go back to reference Szpiech ZA, Xu J, Pemberton TJ, Peng W, Zollner S, Rosenberg NA, Li JZ: Long runs of homozygosity are enriched for deleterious variation. Am J Hum Genet. 2013, 93: 90-102. 10.1016/j.ajhg.2013.05.003.CrossRefPubMedPubMedCentral Szpiech ZA, Xu J, Pemberton TJ, Peng W, Zollner S, Rosenberg NA, Li JZ: Long runs of homozygosity are enriched for deleterious variation. Am J Hum Genet. 2013, 93: 90-102. 10.1016/j.ajhg.2013.05.003.CrossRefPubMedPubMedCentral
12.
go back to reference Rabbitts TH, Forster A, Larson R, Nathan P: Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat Genet. 1993, 4: 175-180. 10.1038/ng0693-175.CrossRefPubMed Rabbitts TH, Forster A, Larson R, Nathan P: Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat Genet. 1993, 4: 175-180. 10.1038/ng0693-175.CrossRefPubMed
13.
go back to reference Kwiatkowski TJ, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T, et al: Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009, 323: 1205-1208. 10.1126/science.1166066.CrossRefPubMed Kwiatkowski TJ, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T, et al: Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009, 323: 1205-1208. 10.1126/science.1166066.CrossRefPubMed
14.
go back to reference Kratz CP, Niemeyer CM, Zenker M: An unexpected new role of mutant Ras: perturbation of human embryonic development. J Mol Med. 2007, 85: 227-235. 10.1007/s00109-006-0135-4.CrossRefPubMedPubMedCentral Kratz CP, Niemeyer CM, Zenker M: An unexpected new role of mutant Ras: perturbation of human embryonic development. J Mol Med. 2007, 85: 227-235. 10.1007/s00109-006-0135-4.CrossRefPubMedPubMedCentral
15.
go back to reference MacArthur DG, Balasubramanian S, Frankish A, Huang N, Morris J, Walter K, Jostins L, Habegger L, Pickrell JK, Montgomery SB, et al: A systematic survey of loss-of-function variants in human protein-coding genes. Science. 2012, 335: 823-828. 10.1126/science.1215040.CrossRefPubMedPubMedCentral MacArthur DG, Balasubramanian S, Frankish A, Huang N, Morris J, Walter K, Jostins L, Habegger L, Pickrell JK, Montgomery SB, et al: A systematic survey of loss-of-function variants in human protein-coding genes. Science. 2012, 335: 823-828. 10.1126/science.1215040.CrossRefPubMedPubMedCentral
16.
go back to reference Chang JY, He RY, Lin HP, Hsu LJ, Lai FJ, Hong Q, Chen SJ, Chang NS: Signaling from membrane receptors to tumor suppressor WW domain-containing oxidoreductase. Exp Biol Med. 2010, 235: 796-804. 10.1258/ebm.2010.009351.CrossRef Chang JY, He RY, Lin HP, Hsu LJ, Lai FJ, Hong Q, Chen SJ, Chang NS: Signaling from membrane receptors to tumor suppressor WW domain-containing oxidoreductase. Exp Biol Med. 2010, 235: 796-804. 10.1258/ebm.2010.009351.CrossRef
17.
go back to reference Bowes C, Li T, Danciger M, Baxter LC, Applebury ML, Farber DB: Retinal degeneration in the rd mouse is caused by a defect in the beta subunit of rod cGMP-phosphodiesterase. Nature. 1990, 347: 677-680. 10.1038/347677a0.CrossRefPubMed Bowes C, Li T, Danciger M, Baxter LC, Applebury ML, Farber DB: Retinal degeneration in the rd mouse is caused by a defect in the beta subunit of rod cGMP-phosphodiesterase. Nature. 1990, 347: 677-680. 10.1038/347677a0.CrossRefPubMed
18.
go back to reference Olichon A, Baricault L, Gas N, Guillou E, Valette A, Belenguer P, Lenaers G: Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem. 2003, 278: 7743-7746. 10.1074/jbc.C200677200.CrossRefPubMed Olichon A, Baricault L, Gas N, Guillou E, Valette A, Belenguer P, Lenaers G: Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem. 2003, 278: 7743-7746. 10.1074/jbc.C200677200.CrossRefPubMed
19.
go back to reference Wang SW, Mu X, Bowers WJ, Kim DS, Plas DJ, Crair MC, Federoff HJ, Gan L, Klein WH: Brn3b/Brn3c double knockout mice reveal an unsuspected role for Brn3c in retinal ganglion cell axon outgrowth. Development. 2002, 129: 467-477.PubMed Wang SW, Mu X, Bowers WJ, Kim DS, Plas DJ, Crair MC, Federoff HJ, Gan L, Klein WH: Brn3b/Brn3c double knockout mice reveal an unsuspected role for Brn3c in retinal ganglion cell axon outgrowth. Development. 2002, 129: 467-477.PubMed
20.
go back to reference Aqeilan RI, Hassan MQ, de Bruin A, Hagan JP, Volinia S, Palumbo T, Hussain S, Lee SH, Gaur T, Stein GS, et al: The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism. J Biol Chem. 2008, 283: 21629-21639. 10.1074/jbc.M800855200.CrossRefPubMedPubMedCentral Aqeilan RI, Hassan MQ, de Bruin A, Hagan JP, Volinia S, Palumbo T, Hussain S, Lee SH, Gaur T, Stein GS, et al: The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism. J Biol Chem. 2008, 283: 21629-21639. 10.1074/jbc.M800855200.CrossRefPubMedPubMedCentral
21.
go back to reference Aqeilan RI, Trapasso F, Hussain S, Costinean S, Marshall D, Pekarsky Y, Hagan JP, Zanesi N, Kaou M, Stein GS, et al: Targeted deletion of Wwox reveals a tumor suppressor function. Proc Natl Acad Sci USA. 2007, 104: 3949-3954. 10.1073/pnas.0609783104.CrossRefPubMedPubMedCentral Aqeilan RI, Trapasso F, Hussain S, Costinean S, Marshall D, Pekarsky Y, Hagan JP, Zanesi N, Kaou M, Stein GS, et al: Targeted deletion of Wwox reveals a tumor suppressor function. Proc Natl Acad Sci USA. 2007, 104: 3949-3954. 10.1073/pnas.0609783104.CrossRefPubMedPubMedCentral
22.
go back to reference Aqeilan RI, Hagan JP, de Bruin A, Rawahneh M, Salah Z, Gaudio E, Siddiqui H, Volinia S, Alder H, Lian JB, et al: Targeted ablation of the WW domain-containing oxidoreductase tumor suppressor leads to impaired steroidogenesis. Endocrinology. 2009, 150: 1530-1535. 10.1210/en.2008-1087.CrossRefPubMedPubMedCentral Aqeilan RI, Hagan JP, de Bruin A, Rawahneh M, Salah Z, Gaudio E, Siddiqui H, Volinia S, Alder H, Lian JB, et al: Targeted ablation of the WW domain-containing oxidoreductase tumor suppressor leads to impaired steroidogenesis. Endocrinology. 2009, 150: 1530-1535. 10.1210/en.2008-1087.CrossRefPubMedPubMedCentral
Metadata
Title
The supposed tumor suppressor gene WWOX is mutated in an early lethal microcephaly syndrome with epilepsy, growth retardation and retinal degeneration
Authors
Ghada Abdel-Salam
Michaela Thoenes
Hanan H Afifi
Friederike Körber
Daniel Swan
Hanno Jörn Bolz
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2014
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/1750-1172-9-12

Other articles of this Issue 1/2014

Orphanet Journal of Rare Diseases 1/2014 Go to the issue